Inspire Medical Systems, Inc.
About Inspire Medical Systems, Inc.
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and All other countries wherein, it generates a majority of its revenue from the United States. Its segment revenues are derived from the sales of its product, the Inspire system, to hospitals and ambulatory surgery centers in the U.S. and in selected countries in Europe and the Asia Pacific region.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $912.0M
- Net income
- $145.4M
- Total assets
- $907.3M
- Market cap
- $1.2B
- Gross margin
- 85.4%
- Operating margin
- 5.6%
- Net margin
- 15.9%
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $912.0M
- Cost of revenue
- $133.2M
- Gross profit
- $778.8M
- Operating expenses
- $727.8M
- Operating income
- $51.0M
- Income tax
- -$79.7M
- Net income
- $145.4M
- EPS (basic)
- $4.95
- EPS (diluted)
- $4.89
Balance sheet
- Total assets
- $907.3M
- Current assets
- $583.7M
- Total liabilities
- $126.2M
- Current liabilities
- $96.1M
- Shareholders’ equity
- $781.2M
Cash flow
- Operating cash flow
- $117.0M
- Investing cash flow
- $21.4M
- Financing cash flow
- -$183.4M
- Net cash flow
- -$45.3M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year
52-week range
- Market cap
- $1.2B
- P/E ratio
- 8.6
- EPS (diluted)
- $4.89
- Shares outstanding
- 28.3M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- May 3, 2018
Market data by Polygon.io · prices are 15-minute delayed
At a glance
- Profitable — net income of $145.4M in FY2025.
- Revenue grew 291% from FY2021 to FY2025.
- Gross margin of 85.4%, net margin 15.9%.
- Trading 74% below its 52-week high.
- Valued at a price-to-earnings (P/E) ratio of 8.6.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Inspire Medical Systems, Inc..
Write a review
News about Inspire Medical Systems, Inc.
News & sentiment via Polygon.io
